KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:PETX
Delisted

Aratana Therapeutics Stock Price (Quote)

$4.92
+0 (+0%)
At Close: Sep 20, 2019

Range Low Price High Price Comment
30 days $4.92 $4.92 Friday, 20th Sep 2019 PETX stock ended at $4.92. During the day the stock fluctuated 0% from a day low at $4.92 to a day high of $4.92.
90 days $4.80 $5.30
52 weeks $3.30 $7.16

Historical Aratana Therapeutics prices

Date Open High Low Close Volume
Feb 25, 2016 $3.40 $3.42 $3.18 $3.34 356 400
Feb 24, 2016 $3.50 $3.50 $3.20 $3.38 457 100
Feb 23, 2016 $3.33 $3.68 $3.31 $3.54 605 700
Feb 22, 2016 $3.18 $3.41 $3.13 $3.36 463 200
Feb 19, 2016 $3.26 $3.26 $3.04 $3.13 514 400
Feb 18, 2016 $3.50 $3.50 $3.14 $3.29 693 600
Feb 17, 2016 $3.14 $3.43 $3.10 $3.36 505 500
Feb 16, 2016 $2.79 $3.16 $2.73 $3.09 506 100
Feb 12, 2016 $2.72 $2.73 $2.56 $2.70 420 400
Feb 11, 2016 $2.68 $2.77 $2.64 $2.65 452 100
Feb 10, 2016 $2.70 $2.98 $2.60 $2.75 452 400
Feb 09, 2016 $2.90 $3.02 $2.67 $2.68 976 300
Feb 08, 2016 $3.20 $3.25 $2.89 $2.96 638 800
Feb 05, 2016 $3.56 $3.56 $3.25 $3.29 747 200
Feb 04, 2016 $3.54 $4.19 $3.42 $3.59 1 789 700
Feb 03, 2016 $3.24 $3.35 $3.10 $3.30 319 100
Feb 02, 2016 $3.31 $3.37 $3.13 $3.20 373 100
Feb 01, 2016 $3.33 $3.46 $3.21 $3.35 438 300
Jan 29, 2016 $3.14 $3.38 $3.14 $3.37 484 100
Jan 28, 2016 $3.24 $3.25 $3.04 $3.15 554 300
Jan 27, 2016 $3.24 $3.32 $2.99 $3.12 792 900
Jan 26, 2016 $3.53 $3.60 $3.13 $3.24 2 182 100
Jan 25, 2016 $3.16 $3.29 $3.09 $3.19 608 200
Jan 22, 2016 $3.20 $3.30 $3.08 $3.14 488 900
Jan 21, 2016 $3.12 $3.43 $3.07 $3.13 794 900
Click to get the best stock tips daily for free!

About Aratana Therapeutics

Aratana Therapeutics Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of biopharmaceutical products for the companion animals worldwide. Its product portfolio includes various therapeutic candidates consisting of small molecule pharmaceuticals and large molecule biologics that target various opportunities in serious medical conditions in pets. The company develops AT-001, a prostag... PETX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT